| PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity SR Gordon, RL Maute, BW Dulken, G Hutter, BM George, MN McCracken, ... Nature 545 (7655), 495-499, 2017 | 2027 | 2017 |
| Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues S Zanganeh, G Hutter, R Spitler, O Lenkov, M Mahmoudi, A Shaw, ... Nature nanotechnology 11 (11), 986-994, 2016 | 1537 | 2016 |
| Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors S Gholamin, SS Mitra, AH Feroze, J Liu, SA Kahn, M Zhang, R Esparza, ... Science translational medicine 9 (381), eaaf2968, 2017 | 403 | 2017 |
| Anti-CD47 Treatment Stimulates Phagocytosis of Glioblastoma by M1 and M2 Polarized Macrophages and Promotes M1 Polarized Macrophages In Vivo M Zhang, G Hutter, SA Kahn, TD Azad, S Gholamin, CY Xu, J Liu, ... PloS one 11 (4), e0153550, 2016 | 340 | 2016 |
| Microglia are effector cells of CD47-SIRPα antiphagocytic axis disruption against glioblastoma G Hutter, J Theruvath, CM Graef, M Zhang, MK Schoen, EM Manz, ... Proceedings of the National Academy of Sciences 116 (3), 997-1006, 2019 | 234 | 2019 |
| IDH/MGMT-driven molecular classification of low-grade glioma is a strong predictor for long-term survival S Leu, S von Felten, S Frank, E Vassella, I Vajtai, E Taylor, M Schulz, ... Neuro-oncology 15 (4), 469-479, 2013 | 210 | 2013 |
| No superoxide dismutase activity of cellular prion protein in vivo G Hutter, FL Heppner, A Aguzzi Walter de Gruyter 384 (9), 1279-1285, 2003 | 170 | 2003 |
| Engulfment of cerebral apoptotic bodies controls the course of prion disease in a mouse strain–dependent manner J Kranich, NJ Krautler, J Falsig, B Ballmer, S Li, G Hutter, P Schwarz, ... Journal of Experimental Medicine 207 (10), 2271-2281, 2010 | 134 | 2010 |
| Risk factors for postoperative CSF leakage after elective craniotomy and the efficacy of fleece-bound tissue sealing against dural suturing alone: a randomized controlled trial G Hutter, S von Felten, MH Sailer, M Schulz, L Mariani Journal of neurosurgery 121 (3), 735-744, 2014 | 125 | 2014 |
| COVID-19 and preexisting comorbidities: risks, synergies, and clinical outcomes B Bigdelou, MR Sepand, S Najafikhoshnoo, JAT Negrete, M Sharaf, ... Frontiers in immunology 13, 890517, 2022 | 98 | 2022 |
| The role of calorie restriction and SIRT1 in prion-mediated neurodegeneration D Chen, AD Steele, G Hutter, J Bruno, A Govindarajan, E Easlon, SJ Lin, ... Experimental gerontology 43 (12), 1086-1093, 2008 | 89 | 2008 |
| SIRPα polymorphisms, but not the prion protein, control phagocytosis of apoptotic cells M Nuvolone, V Kana, G Hutter, D Sakata, SM Mortin-Toth, G Russo, ... Journal of Experimental Medicine 210 (12), 2539-2552, 2013 | 81 | 2013 |
| Heat shock factor 1 regulates lifespan as distinct from disease onset in prion disease AD Steele, G Hutter, WS Jackson, FL Heppner, AW Borkowski, OD King, ... Proceedings of the National Academy of Sciences 105 (36), 13626-13631, 2008 | 80 | 2008 |
| Severe Neuro-COVID is associated with peripheral immune signatures, autoimmunity and neurodegeneration: a prospective cross-sectional study MM Etter, TA Martins, L Kulsvehagen, E Pössnecker, W Duchemin, ... Nature communications 13 (1), 6777, 2022 | 69 | 2022 |
| Targeting immunoliposomes to EGFR-positive glioblastoma B Kasenda, D König, M Manni, R Ritschard, U Duthaler, E Bartoszek, ... ESMO open 7 (1), 100365, 2022 | 67 | 2022 |
| Repurposing rotavirus vaccines for intratumoral immunotherapy can overcome resistance to immune checkpoint blockade T Shekarian, E Sivado, AC Jallas, S Depil, J Kielbassa, ... Science translational medicine 11 (515), eaat5025, 2019 | 61 | 2019 |
| Notch1 regulates the initiation of metastasis and self-renewal of Group 3 medulloblastoma SA Kahn, X Wang, RT Nitta, S Gholamin, J Theruvath, G Hutter, TD Azad, ... Nature communications 9 (1), 4121, 2018 | 50 | 2018 |
| Tumor-associated macrophages, nanomedicine and imaging: the axis of success in the future of cancer immunotherapy S Zanganeh, R Spitler, G Hutter, JQ Ho, M Pauliah, M Mahmoudi Immunotherapy 9 (10), 819-835, 2017 | 49 | 2017 |
| Abdominal seeding of an atypical teratoid/rhabdoid tumor of the pineal gland along a ventriculoperitoneal shunt catheter B Ingold, M Moschopulos, G Hutter, H Seeger, B Röthlisberger, H Landolt, ... Acta neuropathologica 111, 56-59, 2006 | 41 | 2006 |
| Targeting the Siglec–sialic acid axis promotes antitumor immune responses in preclinical models of glioblastoma P Schmassmann, J Roux, A Buck, N Tatari, S Hogan, J Wang, ... Science translational medicine 15 (705), eadf5302, 2023 | 40 | 2023 |
Irving WeissmanDirector, Institute of Stem Cell Biology and Regenerative MedicineVerified email at stanford.edu
